Patents by Inventor Soo Yeon Jang

Soo Yeon Jang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240010635
    Abstract: SUMMARY OF THE INVENTION The present invention relates to novel indirubin derivatives having heterobicyclic moieties, and use thereof as fms-like tyrosine kinase 3 (FLT3) and rearranged during transfection (RET) kinase inhibitors. The compound of the present invention effectively inhibits the activity of FLT3 and RET kinases, and thus may be useful for preventing or treating mutant FLT3 and mutant RET-related diseases, particularly acute myeloid leukemia.
    Type: Application
    Filed: December 23, 2022
    Publication date: January 11, 2024
    Applicant: Pelemed Co., Ltd.
    Inventors: Soo Yeon Jang, Myung Jin Kim, Jin Hee Park, So Deok Lee, Su Jin Oh, Eun Ji Lee, Yong Chul Kim, Woo Chan Kim, Je Heon Lee